SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

The transcription factor ERG regulates a low shear stress-induced anti-thrombotic pathway in the microvasculature.

Peghaire, C; Dufton, NP; Lang, M; Salles-Crawley, II; Ahnström, J; Kalna, V; Raimondi, C; Pericleous, C; Inuabasi, L; Kiseleva, R; et al. Peghaire, C; Dufton, NP; Lang, M; Salles-Crawley, II; Ahnström, J; Kalna, V; Raimondi, C; Pericleous, C; Inuabasi, L; Kiseleva, R; Muzykantov, VR; Mason, JC; Birdsey, GM; Randi, AM (2019) The transcription factor ERG regulates a low shear stress-induced anti-thrombotic pathway in the microvasculature. Nat Commun, 10 (1). p. 5014. ISSN 2041-1723 https://doi.org/10.1038/s41467-019-12897-w
SGUL Authors: Salles-Crawley, Isabelle Irene

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (5MB) | Preview
[img]
Preview
PDF (Supplementary Information) Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Endothelial cells actively maintain an anti-thrombotic environment; loss of this protective function may lead to thrombosis and systemic coagulopathy. The transcription factor ERG is essential to maintain endothelial homeostasis. Here, we show that inducible endothelial ERG deletion (ErgiEC-KO) in mice is associated with spontaneous thrombosis, hemorrhages and systemic coagulopathy. We find that ERG drives transcription of the anticoagulant thrombomodulin (TM), as shown by reporter assays and chromatin immunoprecipitation. TM expression is regulated by shear stress (SS) via Krüppel-like factor 2 (KLF2). In vitro, ERG regulates TM expression under low SS conditions, by facilitating KLF2 binding to the TM promoter. However, ERG is dispensable for TM expression in high SS conditions. In ErgiEC-KO mice, TM expression is decreased in liver and lung microvasculature exposed to low SS but not in blood vessels exposed to high SS. Our study identifies an endogenous, vascular bed-specific anticoagulant pathway in microvasculature exposed to low SS.

Item Type: Article
Additional Information: Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2019
Keywords: Animals, Cells, Cultured, Endothelial Cells, Gene Expression Regulation, Humans, Kruppel-Like Transcription Factors, Mice, Knockout, Microvessels, Promoter Regions, Genetic, Signal Transduction, Stress, Mechanical, Thrombomodulin, Thrombosis, Transcriptional Regulator ERG, Cells, Cultured, Endothelial Cells, Animals, Mice, Knockout, Humans, Thrombosis, Thrombomodulin, Signal Transduction, Gene Expression Regulation, Stress, Mechanical, Kruppel-Like Transcription Factors, Promoter Regions, Genetic, Microvessels, Transcriptional Regulator ERG, MD Multidisciplinary
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Nat Commun
ISSN: 2041-1723
Language: eng
Dates:
DateEvent
1 November 2019Published
30 September 2019Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
FS/16/22/32045British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
PG/14/90/31219British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
PG/17/22/32868British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
21223Versus ArthritisUNSPECIFIED
FS/12/60/29874British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
T32 HL007971NHLBI NIH HHSUNSPECIFIED
PG/17/42/33039British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
RG/11/17/29256British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
RG/17/4/32662British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
1R01 HL 128398-04National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
5T32HL007971-18National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
PubMed ID: 31676784
Web of Science ID: WOS:000493712700007
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113735
Publisher's version: https://doi.org/10.1038/s41467-019-12897-w

Actions (login required)

Edit Item Edit Item